Patents/Inventors

Patricia Andres

Bend, ORUS13 patents

13 Patents

US124668352025
Solid Forms of Macrocyclic Compounds, Salts and Formulations Thereof, and Methods of Preparing and Using the Same
Kura Oncology, Inc.
0 cites
US124101842025
Crystalline Forms of a Menin Inhibitor
Kura Oncology, Inc.
0 cites
US123382492025
Crystalline Forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n′-methoxyurea
Takeda Pharmaceutical Company Limited
0 cites
US122864312025
Crystalline Forms of a Kras G12C Inhibitor
MIRATI THERAPEUTICS, Inc.
0 cites
US122811132025
Crystalline Forms of a Kras G12C Inhibitor
MIRATI THERAPEUTICS, Inc.
0 cites
US121520372024
Crystalline Succinate Salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk Inhibitor
Kronos Bio, Inc.
0 cites
US121394942024
Morphic Forms of G1T38 and Methods of Manufacture Thereof
G1 Therapeutics, Inc.
0 cites
US119760892024
Methods for the Purification of L-glufosinate
BASF SE
0 cites
US118979082024
Methods for the Purification of L-glufosinate
BASF SE
0 cites
US118979092024
Methods for the Purification of L-glufosinate
BASF SE
0 cites
US117878192023
Crystalline Salt of a Multi-tyrosine Kinase Inhibitor, Method of Preparation, and Use Thereof
MIRATI THERAPEPEUTICS, Inc.
0 cites
US117730982023
Solid Forms of a Toll-like Receptor Modulator
GILEAD SCIENCES, Inc.
0 cites
US116344422023
Methods for the Purification of L-glufosinate
BASF SE
0 cites